Craig-Hallum bulish on Myriad Genetics, initiates with a Buy
As previously reported, Craig-Hallum initiated coverage of Myriad Genetics (MYGN) with a Buy rating and $29 price target. The firm believes the ...
Myriad Genetics initiated with a Buy at Craig-Hallum
Craig-Hallum initiated coverage of Myriad Genetics (MYGN) with a Buy rating and $29 price target Maximize Your Portfolio with Data Driven ...
Zacks.com on MSN1d
MYGN Stock Might Rise on Collaboration With CancerCARE
Myriad Genetics, Inc. MYGN recently announced an agreement to enhance education and access to hereditary cancer testing for CancerCARE for Life members. Under the agreement, more than 1 million ...
GeneDx CEO wants genetic testing for every newborn
GeneDx CEO Katherine Stueland likes the potential of newborn testing, but she says her Stamford, Connecticut, company is still studying the idea. A potential challenge: Insurers would have to embrace ...
KBC Group NV Purchases 3,334 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
KBC Group NV raised its stake in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 132.8% in the fourth quarter, ...
Yahoo Finance8d
Myriad Genetics Unveils Groundbreaking Eight Weeks’ Gestation NIPT Study Results at Society for Maternal-Fetal Medicine Conference
SALT LAKE CITY, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it will unveil groundbreaking research ...
DNA Testing Market Increasing Size, Demand, Growth Rate, And Forecast 2033 - Emergen Research
Emergen Research Logo The DNA Testing market is expected to grow from an estimated USD 12.51 billion in 2024 to USD 81.82 billion in 2033, ...
manilatimes14d
Myriad Genetics Unveils Groundbreaking Eight Weeks' Gestation NIPT Study Results at Society for Maternal-Fetal Medicine Conference
SALT LAKE CITY, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it will unveil groundbreaking research at ...
Webindia 12314d
Datar Cancer Genetics to Provide Groundbreaking Video-Enhanced Results of In-Vitro Chemotherapy Effectiveness Tests for Cancer Patients
New Delhi [India] / London [UK] / Munich [Germany], January 28: Datar Cancer Genetics (DCG) has launched a revolutionary video-reporting service for in-vitro chemosensitivity testing, powered by ...
PR Newswire15d
SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities
BOSTON, MA and ROLLE, Switzerland, Jan. 28, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine ...